FrancophonIA/ELRC3.0 huggingface dataset:
English: For any information about this veterinary medicinal product, please contact the local representative of the marketing authorisation holder.
Croatian: Za bilo koju informaciju o ovom veterinarsko-medicinskom proizvodu molimo kontaktirajte lokalnog zastupnika nositelja odobrenja za stavljanje u promet.
English: Propylene glycol methyl ether.
Croatian: Propilen glikol metil eter
English: In the absence of information, it is recommended not to apply other topical preparations simultaneously on the same lesions.
Croatian: U odsustvu informacija ne preporučuje se istovremena primjena s drugim topikalnim preparatima na istim lezijama.
English: The holder of this marketing authorisation must inform the European Commission about the marketing plans for the medicinal product authorised by this decision.
Croatian: Nositelj odobrenja mora obavijestiti Europsku komisiju o planovima za stavljanje u promet tog medicinskog proizvoda.
English: Care should be taken to avoid spraying into the eyes of the animal.
Croatian: Izbjegnite raspršivanje u oči životinje.
English: Topical application of diesters results in high therapeutic index: high local activity with reduced systemic secondary effects.
Croatian: Lokalna aplikacija diestera rezultira visokim terapijskim indeksom, višom lokalnom aktivnošću uz smanjene sustavnih sekundarne efekte.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance:
Croatian: KVALITATIVNI I KVANTITATIVNI SASTAV Djelatna tvar
English: Since glucocorticosteroids are known to slow growth, use in young animals (under 7 months of age) shall be based on the risk-benefit assessment and subject to regular clinical evaluations.
Croatian: Kako glukokortikoidi usporavaju rast, primjena u mladih životinja (mlađih od 7 mjeseci) treba biti temeljena na procjeni koristi i rizika i na redovnoj kliničkoj procjeni.
English: AUTHORISATION
Croatian: ODOBRENJA
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated ) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated ) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports)
Croatian: Učestalost nuspojava definirana je korištenjem slijedeće terminologije: - Vrlo često (više od 1 od 10 životinja ima nuspojave) - Često (više od 1 ali manje od 10 životinja od 100 pod terapijom) - Neuobičajeno (više od 1 ali manje od 10 životinja od 1000 životinja pod terapijom) - Rijetko (više od 1 ali manje od 10 životinja od 10,000 životinja pod terapijom)
English: Not all pack sizes may be marketed.
Croatian: Sve veličine pakiranja ne mogu biti stavljene na tržište.
English: The solvent in this product may stain certain materials including painted, varnished or other household surfaces or furnishings.
Croatian: Otapalo u ovom proizvodu može ostavljati mrlje na određenim materijalima, uključujući i obojene, lakirane ili druge kućne površine ili namještaj.
English: SPECIAL WARNING(S), IF NECESSARY Read the package leaflet before use.
Croatian: POSEBNA UPOZORENJA, UKOLIKO JE POTREBNO Pročitajte uputu u pakiranju prije primjene.
English: VIRBAC Hellas SA 13o χλμ Ε.Ο.
Croatian: VIRBAC Hellas SA 13o χλμ Ε.Ο. ΑθηνώνΛαμίας,
English: EXPIRY DATE EXP {month/year} Once opened, use by 6 months.
Croatian: ROK VALJANOSTI EXP {mjesec/godina} Jednom otvoren, upotrijebiti do 6 mjeseci.
English: Box containing a polyethylene terephtalate (PET) or high density polyethylene (HDPE) bottle filled with 31 ml or 76 ml of solution, closed with an aluminium screw cap or a white plastic screw cap and a pump spray.
Croatian: Kutija sadrži bocu od polietilena tereftalata (PET) ili od polietilena visoke gustoće (HDPE) napunjenu s 31 ml ili 76 mL otopine, zatvorenu aluminjskom kapom s navojima ili bijelom plastičnom kapicom s navojima i pumpicu za raspršivanje.
English: Special precautions for use in animals
Croatian: Posebne mjere predostrožnosti za korištenje na životinjama
English: Marketing authorisation holder and manufacturer:
Croatian: Naziv nositelja odobrenja za stavljanje u promet i proizvođača:
English: Hydrocortisone aceponate thus accumulates in the dog's skin allowing local efficacy at low dosage.
Croatian: HCA se stoga akumulira u kožu psa što omogućava lokalnu djelotvornost u manjim dozama.
English: In case of accidental skin contact, it is recommended to wash thoroughly with water.
Croatian: U slučaju nehotičnog kontakta s kožom, preporučeno je odmah temeljito isprati vodom.
English: DE: Deutschland VIRBAC Tierarzneimittel GmbH Rögen 20
Croatian: DE: Deutschland VIRBAC Tierarzneimittel GmbH
English: THE WORDS “FOR ANIMAL TREATMENT ONLY” AND CONDITIONS OR
Croatian: 13. RIJEČI “ SAMO ZA PRIMJENU NA ŽIVOTINJAMA ” I UVJETI ILI OGRANIČENJA
English: In 12 dogs suffering from atopic dermatitis, after topical application on the skin at the recommended therapeutic dosage for 28 to 70 consecutive days, no noticeable effect on the systemic cortisol level was observed.
Croatian: U 12 pasa oboljelih od atopijskog dermatitisa nakon lokalne aplikacije na kožu preporučene doze tijekom 28-70 uzastopnih dana nije bilo primjetnih efekata na sustavni nivo kortizola.
English: The veterinary medicinal product is then applied by activating the pump spray, from a distance of about 10 cm of the area to be treated.
Croatian: Veterinarsko medicinski proizvod primjenjuje se tako što se aktivira sprej pumpica sa udaljenosti od oko 10 cm od površine koja se tretira.
English: In case of accidental ingestion, seek medical advice immediately and show the leaflet or the label to the physician.
Croatian: U slučaju nehotičnog gutanja, odmah potražiti pomoć liječnika i pokažite mu uputu o VMP ili etiketu.
English: Hydrocortisone aceponate is a dermocorticoid with a potent intrinsic glucocorticoid activity which means a relief of both inflammation and pruritus leading to a quick improvement of skin lesions observed in case of inflammatory and pruritic dermatosis.
Croatian: Hidrokortizon aceponat (HCA) je dermokortikoid s jakom intrinzičnom glukokortikoidnom aktivnošću što znači olakšanje upalnih procesa i svrbeža i vodi ka brzom poboljšanju lezija na koži koje se opažaju kod upalnih i pruritičnih dermatoza.
English: SPECIAL WARNING(S), IF NECESSARY Not applicable.
Croatian: POSEBNA UPOZORENJA, UKOLIKO JE POTREBNO
English: Carton box with a PET bottle of 31ml Carton box with a PET bottle of 76ml Carton box with a HDPE bottle of 31ml Carton box with a HDPE bottle of 76ml
Croatian: Kartonska kutija s PET bočicom od 31 ml Kartonska kutija s PET bočicom od 76 ml Kartonska kutija s HDPE bočicom od 31 ml Kartonska kutija s HDPE bočicom od 76 ml
English: Total body surface treated should not exceed a surface corresponding for example to a treatment of two flanks from the spine to the mammary chains including the shoulders and the thighs.
Croatian: Cijela tretirana površina ne bi smjela premašiti površinu koja primjerice odgovara tretmanu dviju bočnih strana od hrpta do mamarnog kompleksa, uključujući pleća i bedra.
English: In the case of concurrent microbial disease or parasitic infestation, the dog should receive appropriate treatment for such condition.
Croatian: U slučajevima istovremene infekcije bakterijama ili parazitima psu treba davati odgovarajuću terapiju.
English: Pharmacotherapeutic group: Glucorticosteroids, dermatological preparations.
Croatian: Farmakoterapijska grupa: glukokortikoidi, dermatološki pripravci ATCvet kod: QD07AC
English: After topical application on the skin at the recommended therapeutic dosage and twice the recommended duration of treatment and at up to a body surface corresponding to the two flanks, from the spine to the mammary chains including the shoulder and the thighs, no systemic effects are observed.
Croatian: Nakon lokalne aplikacije na kožu u preporučenoj terapijskoj dozi i dvostruko dulje od preporučenog trajanja tretmana i na površini tijela koja odgovara dvostrukoj bočnoj površini od hrpta do mamarnog kompleksa s plećima i bedrima, nisu opaženi sustavni učinci.
English: Otherwise, use only according to the risk-benefit assessment and subject the dog to regular clinical evaluations.
Croatian: U drugačijem slučaju upotrebljavati samo na osnovu procjene odnosa rizika i koristi, a psa podvrgnuti redovnoj kliničkoj procjeni.
English: Allow the application site to dry before permitting contact with such materials.
Croatian: Prije kontakta sa takvim materijalima pustiti da se mjesto aplikacije osuši.
English: A. MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND
Croatian: PROIZVOĐAČ BIOLOŠKI DJELATNE TVARI I NOSITELJ
English: CONDITIONS OR RESTRICTIONS OF THE MARKETING AUTHORISATION REGARDING SUPPLY AND USE
Croatian: UVJETI ILI OGRANIČENJA ODOBRENJA ZA STAVLJANJE U PROMET U POGLEDU OPSKRBE I PRIMJENE
English: Read the package leaflet before use.
Croatian: Pročitajte uputu u pakiranju prije primjene.
English: In case of conditions requiring an extended treatment, the responsible veterinarian should subject the use of the veterinary medicinal product to the risk-benefit assessment.
Croatian: U slučaju potrebe za produženim tretmanom, odgovorni veterinar treba napraviti procjenu koristi i rizika.
English: Hydrocortisone aceponate 0.584 mg/ml For the full list of excipients, see section 6.1
Croatian: 0,584 mg/ml Potpuni popis pomoćnih tvari vidi u odjeljku 6.1.
English: OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION
Croatian: DRUGI UVJETI ILI OGRANIČENJA ODOBRENJA ZA STAVLJANJE U PROMET
English: Shelf-life after first opening the container: 6 months.
Croatian: Rok valjanosti poslije prvog otvaranja spremnika 6 mjeseci.
English: 1055 Budapest Magyarország Teл: +36703387177
Croatian: HU: Magyarország VIRBAC Hungary KFT Szent Istvàn krt.11.II/21. 1055 Budapest Magyarország Teл: +36703387177
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton box with a bottle of 31 ml
Croatian: PODACI NA VANJSKOM PAKOVANJU Kartonska kutija u kojoj je bočica od 31 mL
English: STATEMENT OF ACTIVE SUBSTANCES Hydrocortisone aceponate 0.584 mg/ml
Croatian: Hidrokortizon aceponat 0,584 mg/ml
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton box with a bottle of 76 ml
Croatian: PODACI NA VANJSKOM PAKOVANJU Kartonska kutija u kojoj je bočica od 76 mL
English: RESTRICTIONS REGARDING SUPPLY AND USE, if applicable For animal treatment only - to be supplied only on veterinary prescription.
Croatian: U POGLEDU OPSKRBE I PRIMJENE, ako je primjenjivo Samo za primjenu na životinjama - izdaje se samo na veterinarski recept. 14. RIJEČI “ČUVATI IZVAN POGLEDA
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Bottle of 31 ml
Croatian: OSNOVNI DJELOVI NAPISANI NA MALIM JEDINICAMA UNUTARNJIH PAKOVANJA Polietilenska (PET) boca od 31 ml
English: VIRBAC España SA Angel Guimerá 179-181 08950 Esplugues de Llobregat (Barcelona)
Croatian: 08950 Esplugues de Llobregat (Barcelona) España
English: Presented as a volatile spray, this veterinary medicinal product does not require any massage.
Croatian: Kako je ovaj veterinarsko medicinski proizvod hlapljiv, masaža poslije primjene nije potrebna.
English: NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER VIRBAC
Croatian: 15. NAZIV I ADRESA NOSITELJA ODOBRENJA ZA STAVLJANJE U PROMET VIRBAC
English: METHOD AND ROUTE(S) OF ADMINISTRATION Cutaneous use.
Croatian: NAČIN I PUT(EVI) PRIMJENE Za kožu.
English: PHARMACEUTICAL FORM Cutaneous spray, solution.
Croatian: OBLIK Sprej za kožu, otopina
English: HDPE bottle of 76ml: EU/2/06/069/004
Croatian: HDPE bočica od 76 ml: EU/2/06/069/004
English: MANUFACTURER RESPONSIBLE FOR BATCH RELEASE Name and address of the manufacturer(s) responsible for batch release VIRBAC
Croatian: PROIZVODNJU ODGOVORAN ZA PUŠTANJE SERIJE U PROMET Naziv i adresa proizvođača odgovornog za otpuštanje serije u promet VIRBAC
English: WITHDRAWAL PERIOD(S) Not applicable.
Croatian: C. IZVJEŠĆE O MRL Nije primjenjivo.
English: LT: Lietuva VIRBAC
Croatian: LT: Lietuva
English: Carton with a HDPE bottle of 31ml: EU/2/06/069/003
Croatian: Kutija s HDPE bočicom od 31 ml: EU/2/06/069/003
English: NAME OF THE VETERINARY MEDICINAL PRODUCT CORTAVANCE 0.584 mg/ml cutaneous spray solution for dogs Hydrocortisone aceponate
Croatian: NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA CORTAVANCE 0,584 mg/ml sprej za kožu otopina za pse Hidrokortizon aceponat
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).>
Croatian: - Jako rijetko (manje od 1 životinje u 10,000 životinja pod terapijom uključujući i izolirane slučajeve).
English: NAME OF THE VETERINARY MEDICINAL PRODUCT CORTAVANCE 0.584 mg/ml cutaneous spray solution for dogs
Croatian: NAZIV VETERINARSKO-MEDICINSKOG PROIZVODA CORTAVANCE 0,584 mg/ml sprej za kožu otopina za pse
English: MARKETING AUTHORISATION NUMBER(S) Carton with a PET bottle of 31ml: EU/2/06/069/002
Croatian: 16. BROJ(EVI) ODOBRENJA ZA STAVLJANJE U PROMET Kutija s PET bočicom od 31ml: EU/2/06/069/002
English: MARKETING AUTHORISATION NUMBER(S) PET bottle of 76ml: EU/2/06/069/001
Croatian: 16. BROJ(EVI) ODOBRENJA ZA STAVLJANJE U PROMET PET bočica od 76 ml: EU/2/06/069/001
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGE Bottle of 76 ml
Croatian: PODACI NA UNUTARNJEM PAKOVANJU Polietilenska (PET) boca od 76 ml
English: EXPIRY DATE EXP {MM/AA/AA} Once opened, use by 6 months.
Croatian: Jednom odčepljen/otvoren primijeniti u roku 6 mjeseci.
English: ROUTE(S) OF ADMINISTRATION Cutaneous use.
Croatian: PUT(EVI) PRIMJENE Za kožu
English: PACKAGE LEAFLET CORTAVANCE 0.584 mg/ml cutaneous spray solution for dogs
Croatian: UPUTA O VMP CORTAVANCE 0,584 mg/ml, sprej za kožu, otopina za pse
English: MARKETING AUTHORISATION HOLDER VIRBAC
Croatian: UPUTA O VMP
English: MARKETING AUTHORISATION NUMBER(S) Carton box with a PET bottle of 76ml: EU/2/06/069/001
Croatian: 16. BROJ(EVI) ODOBRENJA ZA STAVLJANJE U PROMET Kartonska kutija s PET bočicom od 76ml: EU/2/06/069/001 Kartonska kutija s HDPE bočicom od 76ml: EU/2/06/069/004 17. BROJ PROIZVODNE SERIJE PROIZVOĐAČA Serija {broj}
English: If this happens, do not drive or use any tools or machines until you are feeling well again.
Croatian: nemojte voziti niti koristiti alate ili strojeve dok se ponovno ne počnete osjećati dobro.
English: • Difficulty in sleeping (insomnia).
Croatian: • Otežano spavanje (nesanica).
English: Date of latest renewal: 18 September 2017
Croatian: Datum posljednje obnove odobrenja: 18. rujna 2017
English: Response data are shown in Table 2.
Croatian: Odgovori su prikazani u Tablici 2.
English: Molecular response**
Croatian: Molekularni odgovor**
English: In addition, children have been treated in two phase I studies and one phase II study.
Croatian: Osim toga, djeca su liječena u dva ispitivanja faze I i jednom ispitivanju faze II.
English: Imatinib Teva may do the same to some other medicines.
Croatian: Imatinib Teva može to isto napraviti nekim drugim lijekovima.
English: Your doctor may prescribe a higher or lower dose depending on how you respond to the treatment.
Croatian: Liječnik Vam može propisati višu ili nižu dozu, ovisno o tome kako reagirate na liječenje.
English: PVC/PE/PVdC/PE/PVC//Al blisters OPA/Al/PVC//Al blisters
Croatian: PVC/PE/PVdC/PE/PVC//Al blisteri OPA/Al/PVC//Al blisteri
English: The suspension should be administered immediately after complete disintegration of the tablet(s).
Croatian: Suspenzija se mora primijeniti odmah nakon potpunog raspada tablete(a).
English: • Decreased or increased skin sensitivity.
Croatian: • Smanjena ili povećana osjetljivost kože.
English: If you think you may be allergic but are not sure, ask your doctor for advice.
Croatian: Ako mislite da bi mogli biti alergični, ali niste sigurni, posavjetujte se sa svojim liječnikom.
English: The amount of Imatinib Teva given will depend on your child's condition, body weight and height.
Croatian: Količina Imatiniba Teva koju je potrebno dati ovisiti će o stanju djeteta, tjelesnoj težini i visini.
English: 10000 Zagreb Croatia
Croatian: 10000 Zagreb
English: A major response (0-35%) combines both complete and partial responses.
Croatian: Veliki odgovor (0-35%) je kombinacija potpunih i djelomičnih odgovora.
English: Imatinib Teva can reduce the number of white blood cells, so you might get infections more easily.
Croatian: Imatinib Teva može smanjiti broj bijelih krvnih stanica, pa možete lakše dobiti infekciju.
English: Hands should be washed immediately after handling open capsules.
Croatian: Ruke se trebaju oprati odmah nakon rukovanja s otvorenim kapsulama.
English: • Rapid weight gain.
Croatian: • Brzo dobivanje na težini.
English: Not applicable Not applicable
Croatian: nije primjenjivo nije primjenjivo
English: Some children and adolescents taking Imatinib Teva may have slower than normal growth.
Croatian: Kod neke djece i adolescenata koji uzimaju Imatinib Teva rast može biti sporiji od normalnog.
English: Treatment with imatinib may be interrupted or the dose may be reduced, as recommended in section 4.2.
Croatian: Liječenje imatinibom može se prekinuti ili se doza može smanjiti, kao što je preporučeno u dijelu 4.2.
English: • Recurrence (reactivation) of hepatitis B infection when you have had hepatitis B in the past (a liver infection).
Croatian: • ponovna pojava (ponovna aktivacija) infekcije virusom hepatitisa B ako ste u prošlosti imali hepatitis B (infekciju jetre).
English: The annual rate of progression to accelerated phase or blast crisis decreased with time on therapy and was less than 1% annually in the fourth and fifth years.
Croatian: Godišnja stopa progresije u ubrzanu fazu ili blastičnu krizu smanjivala se s vremenom trajanja terapije, i bila je manja od 1% godišnje u četvrtoj i petoj godini.
English: Do not stop taking Imatinib Teva unless your doctor tells you to.
Croatian: Nemojte prestati uzimati Imatinib Teva, osim ako Vam to ne kaže liječnik.
English: • Unexpected bleeding or bruising (when you have not hurt yourself).
Croatian: • Neočekivano krvarenje ili pojava modrica (kada se niste ozlijedili).
English: Do not use any pack that is damaged or shows signs of tampering.
Croatian: Nemojte koristiti pakovanje koje je oštećeno ili na kojem su vidljivi znakovi otvaranja.
English: • Once the tablet has dissolved, drink everything in the glass straight away.
Croatian: • Jednom kad se tableta otopi, odmah popijte sav sadržaj čaše.
English: Treatment was discontinued permanently because of liver laboratory abnormalities in less than 1% of CML patients.
Croatian: Liječenje je trajno ukinuto zbog abnormalnih jetrenih laboratorijskih nalaza u manje od 1% bolesnika s KML-om.
English: If you have any questions about how Imatinib Teva works or why this medicine has been prescribed for you, ask your doctor.
Croatian: Ako imate bilo kakvih pitanja o tome na koji način djeluje Imatinib Teva, ili zašto je taj lijek Vama propisan, obratite se svom liječniku.
English: Cytogenetic abnormalities were evaluated in 117 of the total population of 176 patients.
Croatian: Citogenetske abnormalnosti su evaluirane u 117 od ukupno 176 bolesnika.
English: There were 59% males and 41% females; 89.9% caucasian and 4.7% black patients.
Croatian: Bilo je 59% muškaraca i 41% žena; 89,9% bijelaca i 4,7% crnaca.
English: A confirmed haematological response was achieved in 71.5% of patients (Table 3).
Croatian: Potvrđeni hematološki odgovor je postignut u 71,5% bolesnika (Tablica 3).
English: As reported in a recent publication 21 of these 65 patients also achieved complete molecular remission with a median follow-up of 28 months (range 13-67 months).
Croatian: Kao što je zabilježeno u nedavnoj publikaciji, 21 od tih 65 bolesnika također je postiglo kompletnu molekularnu remisiju s medijanom praćenja od 28 mjeseci (raspon 13-67 mjeseci).
English: Your doctor has prescribed Imatinib Teva because you suffer from a serious condition.
Croatian: Vaš liječnik je propisao Imatinib Teva, jer patite od ozbiljnog stanja.
English: Imatinib Teva can help you to fight this condition.
Croatian: Imatinib Teva Vam može pomoći u borbi protiv tog stanja.
English: While you are taking Imatinib Teva your doctor will regularly check whether the medicine is working.
Croatian: Dok uzimate Imatinib Teva, liječnik će redovito pratiti da li lijek djeluje.
English: You may become more sensitive to the sun while taking Imatinib Teva.
Croatian: Možete postati osjetljiviji na sunce tijekom uzimanja Imatinib Teva.
English: Similar findings were found based on a 18months landmark analysis.
Croatian: Slični nalazi su nađeni i na temelju analize pokazatelja nakon 18 mjeseci.
English: Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription (such as paracetamol) and including herbal medicines (such as St. John's Wort).
Croatian: Obavijestite svog liječnika ili ljekarnika ako uzimate, nedavno ste uzeli ili biste mogli uzeti bilo koje druge lijekove, uključujući lijekove dobivene bez recepta (poput paracetamola) i biljne pripravke
English: Imatinib pharmacokinetics has not been specifically studied in the elderly.
Croatian: Farmakokinetika imatiniba nije specifično ispitivana u starijih osoba.
English: 8 g to 10 g (single dose): Vomiting and gastrointestinal pain have been reported.
Croatian: 8 g do 10 g (jednokratna doza): zabilježeni su povraćanje i bolovi u trbuhu.
English: The complete molecular response rate was 48% (49 out of 102 evaluable patients).
Croatian: Kompletni molekularni odgovor postignut je u 48% (49 od 102 evaluirana bolesnika).
English: Other medicines and Imatinib Teva
Croatian: Drugi lijekovi i Imatinib Teva
English: 235 adult patients with accelerated phase disease were enrolled.
Croatian: Uključeno je 235 odraslih bolesnika s bolešću u ubrzanoj fazi.
English: Out of the 12 patients enrolled, 9 responded, one completely and 8 partially.
Croatian: Od 12 uključenih bolesnika, 9 je imalo odgovor, jedan kompletni, a 8 parcijalni.
English: At the same dose, the number of stillborn pups as well as those dying between postpartum days 0 and 4 was increased.
Croatian: Pri istoj dozi povećao se broj mrtvorođenih mladunaca, kao i onih koji su uginuli postpartalno između 0. i 4. dana.
English: • Slowing of growth in children and adolescents.
Croatian: • Usporen rast kod djece i adolescenata.
English: Median age was 51 years (range 18-70 years), with 21.9% of patients ≥ 60 years of age.
Croatian: Medijan dobi je iznosio 51 godinu (u rasponu od 18-70 godina), kod čega je 21,9% bolesnika bilo ≥60 godina.
English: The prescribed dose should be administered orally with a meal and a large glass of water to minimise the risk of gastrointestinal irritations.
Croatian: Propisanu dozu treba primjenjivati peroralno, uz obrok i veliku čašu vode, da bi se rizik od gastrointestinalnih iritacija sveo na najmanju moguću mjeru.
English: The most important changes included cardiac hypertrophy and dilatation, leading to signs of cardiac insufficiency in some animals.
Croatian: Najvažnije promjene uključivale su srčanu hipertrofiju i dilataciju, što je, u nekih životinja, dovelo do znakova srčane insuficijencije.
English: These events can usually be managed with either a reduction of the dose or an interruption of treatment with imatinib, but can in rare cases lead to permanent discontinuation of treatment.
Croatian: Te se epizode obično mogu liječiti ili smanjenjem doze ili prekidanjem liječenja imatinibom, no u rijetkim slučajevima mogu dovesti i do trajnog ukidanja lijeka.
English: When needed, discontinuation of Imatinib Teva treatment may be considered.
Croatian: Ukoliko je potrebno, može se razmotriti prekid liječenja Imatinibom Teva.
English: What Imatinib Teva is and what it is used for
Croatian: Što je Imatinib Teva i za što se koristi